Population Studies and Disparities Research Seminars

The goals of the Population Studies and Disparities Research (PSDR) Program include identifying risk factors underlying disease onset and progression, and developing and testing intervention strategies to reduce risk and improve diagnosis, treatment and outcomes. These goals are aimed at decreasing race and ethnicity related disparities and overall disease burden.

Upcoming PSDR Seminar

Friday, March 1, 2024
Noon-1:30 p.m.
Mid Med Research Building
Third Floor Conference Room
87 East Canfield St.
Detroit, MI 48201

"Cannabis Use in Cancer Patients"

Theodore M. Brasky, Ph.D.
Assistant Professor
Department of Internal Medicine
Ohio State University Comprehensive Cancer Center - James
Ohio State University

Please RSVP by February 26, 2024.

Register Now

Attend by Zoom

Meeting ID: 96382341833
Passcode: 855071

Attend by Zoom

For more information, please contact: Ambrianna May at 313-576-8259 or email maya@karmanos.org.

The Latest From Karmanos Cancer Institute


Detroit Research Team to Develop Novel Strategies to Identify Genetic Contributions to Cancer Risk and Overcome Barriers to Genetic Testing for African Americans

A team of researchers from Wayne State University and the Barbara Ann Karmanos Cancer Institute has received a five-year, $9.6 million grant from ...

Read More

Illuminating Lights, Beautiful Weather Brought Record Attendance to Sk8 to Elimin8 Cancer™ to Benefit Research at Karmanos

Sk8 to Elimin8 Cancer™ Detroit Celebration and Ice Show was another fantastic event this year, bringing out more spectators and raising more money...

Read More

IN THE NEWS: What is Immunotherapy for Non-small Cell Lung Cancer?

HealthCentral Hirva Mamdani, M.D. , medical oncologist and leader of the Thoracic Oncology Multidisciplinary Team at Karmanos, explained how immun...

Read More

Prostate Cancer Aware | The Genetic Risks for Prostate Cancer with Dr. Isaac Powell

Listen Now

WDET | New WSU study finds ‘music medicine’ can help cancer patients

Listen Now

Sunday Edition | Updates in stage III and IVA cervical cancer treatment

Listen Now